miltefosine and biguanides
miltefosine has been researched along with biguanides in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Seal, D | 1 |
Ballet, JJ; Benichou, J; Brasseur, G; Duclos, C; Favennec, L; François, A; Gargala, G; Hellot, MF; Muraine, M; Vasseneix, C | 1 |
Obwaller, A; Polat, ZA; Vural, A; Walochnik, J | 1 |
Arici, MK; Dursun, A; Obwaller, A; Polat, ZA; Vural, A; Walochnik, J | 1 |
Appenheimer, AB; Chodosh, J; Hou, JH; Kang, JJ; Morrill, AM; Rapuano, CJ; Saeed, HN; Thulasi, P; Tu, EY; Vyas, N; Zegans, ME; Zuckerman, R | 1 |
Reviews
1 review(s) available for miltefosine and biguanides
Article | Year |
---|---|
Treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba Keratitis; Amebicides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Contact Lenses; Humans; Neomycin; Phosphorylcholine; Treatment Failure | 2003 |
Other Studies
4 other study(ies) available for miltefosine and biguanides
Article | Year |
---|---|
A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzamidines; Betamethasone; Biguanides; Chronic Disease; Corneal Stroma; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Glucocorticoids; Male; Parasitic Sensitivity Tests; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 2006 |
Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Animals; Antiprotozoal Agents; Benzamidines; Biguanides; Cricetinae; Disease Models, Animal; Humans; Male; Mesocricetus; Phosphorylcholine; Treatment Outcome | 2012 |
Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Animals; Antiprotozoal Agents; Biguanides; Cell Line; Cell Proliferation; Disease Models, Animal; Disinfectants; Drug Therapy, Combination; Fibroblasts; Male; Phosphorylcholine; Rats; Rats, Wistar | 2014 |
Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis.
Topics: Acanthamoeba Keratitis; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Biguanides; Female; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Phosphorylcholine; Retrospective Studies; Salvage Therapy; Treatment Outcome; Visual Acuity; Young Adult | 2021 |